10
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Urinary Exosomes from Bladder Cancer Patients Show a Residual Cancer Phenotype despite Complete Pathological Downstaging

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Invasive urinary bladder cancer shows high recurrence rates after cystectomy even with apparent complete downstaging at cystectomy. Exosomes are nano-sized vesicles important in cell-cell communication, which have been hypothesized to contribute to cancer dissemination and recurrence. The aim of this study was to investigate if pro-carcinogenic exosomes could be detected in urine from histologically downstaged bladder cancer patients. 13 Patients were included in this study. Paired ureter and urine samples from nine patients underwent mass spectrometry, while samples from the remaining patients were used for exosome characterization. At cystectomy, exosomes were isolated from bladder and ureter urine, whereafter quantitative proteome profiling was performed. Urinary exosomes clustered based on whether they came from the bladder, with tumour contact, or the ureters, without tumour contact, even though all came from completely downstaged patients. Proteins overexpressed in exosomes derived from bladder urine contained several oncogenes and were mainly associated with tumour metabolism pathways. Although patients were histologically tumour-free at cystectomy, the bladder urine contained exosomes with a carcinogenic metabolic profile. This suggests a continuous release of exosomes from the bladder, which may promote recurrence at distant sites through metabolic rewiring, even after apparent complete downstaging. These exosomes, coming from either undetected cancer cells or partly transformed cells, are likely to increase the risk of metastasis and encourages cystectomy even in completely downstaged patients.

          Related collections

          Most cited references24

          • Record: found
          • Abstract: found
          • Article: not found

          The metastatic niche: adapting the foreign soil.

          The 'seed and soil' hypothesis for metastasis sets forth the concept that a conducive microenvironment, or niche, is required for disseminating tumour cells to engraft distant sites. This Opinion presents emerging data that support this concept and outlines the potential mechanism and temporal sequence by which changes occur in tissues distant from the primary tumour. To enable improvements in the prognosis of advanced malignancy, early interventions that target both the disseminating seed and the metastatic soil are likely to be required.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            clusterMaker: a multi-algorithm clustering plugin for Cytoscape

            Background In the post-genomic era, the rapid increase in high-throughput data calls for computational tools capable of integrating data of diverse types and facilitating recognition of biologically meaningful patterns within them. For example, protein-protein interaction data sets have been clustered to identify stable complexes, but scientists lack easily accessible tools to facilitate combined analyses of multiple data sets from different types of experiments. Here we present clusterMaker, a Cytoscape plugin that implements several clustering algorithms and provides network, dendrogram, and heat map views of the results. The Cytoscape network is linked to all of the other views, so that a selection in one is immediately reflected in the others. clusterMaker is the first Cytoscape plugin to implement such a wide variety of clustering algorithms and visualizations, including the only implementations of hierarchical clustering, dendrogram plus heat map visualization (tree view), k-means, k-medoid, SCPS, AutoSOME, and native (Java) MCL. Results Results are presented in the form of three scenarios of use: analysis of protein expression data using a recently published mouse interactome and a mouse microarray data set of nearly one hundred diverse cell/tissue types; the identification of protein complexes in the yeast Saccharomyces cerevisiae; and the cluster analysis of the vicinal oxygen chelate (VOC) enzyme superfamily. For scenario one, we explore functionally enriched mouse interactomes specific to particular cellular phenotypes and apply fuzzy clustering. For scenario two, we explore the prefoldin complex in detail using both physical and genetic interaction clusters. For scenario three, we explore the possible annotation of a protein as a methylmalonyl-CoA epimerase within the VOC superfamily. Cytoscape session files for all three scenarios are provided in the Additional Files section. Conclusions The Cytoscape plugin clusterMaker provides a number of clustering algorithms and visualizations that can be used independently or in combination for analysis and visualization of biological data sets, and for confirming or generating hypotheses about biological function. Several of these visualizations and algorithms are only available to Cytoscape users through the clusterMaker plugin. clusterMaker is available via the Cytoscape plugin manager.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.

              In patients with oral squamous cell carcinoma, a high proportion of T cells in the tumor undergo apoptosis, which correlates with Fas ligand (FasL) expression on tumor cells. The present study was done to identify mechanisms responsible for apoptosis of T cells seen in the peripheral circulation of these patients. Sera of 27 patients, normal donor sera, and supernatants of cultured normal or tumor cells were fractionated by size exclusion chromatography and ultracentrifugation to isolate microvesicles. The presence of microvesicle-associated FasL was studied by Western blots, blocking with anti-Fas reagents, and immunoelectron microscopy. Biological activities of microvesicles were tested including the ability to induce apoptosis of Jurkat and T-cell blasts. Semiquantitative analysis of FasL in microvesicles was correlated with caspase-3 activity, DNA fragmentation, cytochrome c release, loss of mitochondrial membrane potential, and TCR-zeta chain expression in lymphocytes. FasL-positive (FasL+) microvesicles were detected in sera of 21 of 27 patients. Microvesicles contained 42 kDa FasL. These microvesicles induced caspase-3 cleavage, cytochrome c release, loss of mitochondrial membrane potential, and reduced TCR-zeta chain expression in target lymphocytes. Biological activity of the FasL+ microvesicles was partially blocked by ZB4 anti-Fas monoclonal antibody. Microvesicle-associated FasL levels correlated with the patients' tumor burden and nodal involvement. Sera of patients with active oral squamous cell carcinoma contain FasL+ microvesicles, which induce the receptor and mitochondrial apoptotic pathways in Jurkat and activated T cells.
                Bookmark

                Author and article information

                Contributors
                Susanne.Gabrielsson@ki.se
                Journal
                Sci Rep
                Sci Rep
                Scientific Reports
                Nature Publishing Group UK (London )
                2045-2322
                6 April 2020
                6 April 2020
                2020
                : 10
                : 5960
                Affiliations
                [1 ]ISNI 0000 0004 1937 0626, GRID grid.4714.6, Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institute, ; Stockholm, Sweden
                [2 ]ISNI 0000 0000 8986 2221, GRID grid.416648.9, Department of Urology, Södersjukhuset, ; Stockholm, Sweden
                [3 ]ISNI 0000 0001 2351 3333, GRID grid.412354.5, Department of Urology, Akademiska University Hospital, ; Uppsala, Sweden
                [4 ]Department of Urology, Västmanland Hospital, Västerås, Sweden
                [5 ]ISNI 0000 0001 1034 3451, GRID grid.12650.30, Department of Urology, Sundsvall Hospital, Sundsvall, Umeå University, ; Umeå, Sweden
                [6 ]ISNI 0000 0000 9241 5705, GRID grid.24381.3c, Department of Clinical Immunology and Transfusion Medicine, Karolinska University Hospital, ; Solna, Sweden
                [7 ]ISNI 0000 0001 1034 3451, GRID grid.12650.30, Department of Surgical and Perioperative Sciences, Urology and Andrology, Umeå University, ; Umeå, Sweden
                Author information
                http://orcid.org/0000-0003-0842-4441
                http://orcid.org/0000-0002-3675-3050
                http://orcid.org/0000-0003-1771-1346
                Article
                62753
                10.1038/s41598-020-62753-x
                7136268
                32249794
                86b578be-04b2-477a-ae29-f741fdf3bb99
                © The Author(s) 2020

                Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.

                History
                : 28 May 2019
                : 20 February 2020
                Funding
                Funded by: Cancer- och Allergifonden
                Funded by: The Regional research committee in the Uppsala-Örebro region Swedish Research Council funding for clinical research in medicine (ALF) in Västerbotten VLL Cancer Research Foundation in Norrland
                Funded by: FundRef https://doi.org/10.13039/501100002794, Cancerfonden (Swedish Cancer Society);
                Award ID: 2016/469
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100007232, Radiumhemmets Forskningsfonder (Cancer Research Foundations of Radiumhemmet);
                Award ID: 131082 and 181103
                Award Recipient :
                Funded by: FundRef https://doi.org/10.13039/501100004348, Stockholms Läns Landsting (Stockholm County Council);
                Award ID: 20140405
                Award Recipient :
                Funded by: The KID grant of the Karolinska Institute
                Categories
                Article
                Custom metadata
                © The Author(s) 2020

                Uncategorized
                bladder cancer,tumour immunology
                Uncategorized
                bladder cancer, tumour immunology

                Comments

                Comment on this article